Vaishali Pharma Rohil Sanjay Desai and appointed
Vaishali Pharma (VAISHALI) said Rohil Sanjay Desai and has been appointed. The company is valued at about ₹91.93 crore.
What happened
In a filing with the NSE on 5 November 2026 at 08:41 PM, Vaishali Pharma (VAISHALI) said that Rohil Sanjay Desai and has been appointed.
From the filing: "Vaishali Pharma Limited has informed the Exchange regarding Appointment of Mr."
Company snapshot
Vaishali Pharma is a micro-cap company, with a market value of about ₹91.93 crore.
The stock last traded at ₹6.81, against a 52-week range of ₹4.75–₹10.2 (33.2% below the high).
Before this filing the shares had moved −18.7% over the month and −13.9% over three months. Average daily turnover over the last 20 sessions was about ₹0.08 crore.
Promoters held 30.54% at the end of Q2 FY27, down 1.07% points from the previous quarter.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 24 | 1.3 | 0.1 |
| Q2 FY26 | 33 | 1.2 | 0.09 |
| Q3 FY26 | 25 | 1.3 | 0.1 |
| Q4 FY26 | 27 | 0.4 | 0.03 |
| Q1 FY27 | 23 | 1.5 | 0.12 |
What history shows
BCEIE's records show 3 previous management change filings from the company since May 2026.
After those filings, the stock fell 1.2% on average the next trading day and was down 4.6% on average after five days (3 filings with price data).
Market-wide, 4,295 management change filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 45% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 14 Aug 2026 | Resignation of Director/KMP/SMP | −1.2% | −4.6% |
| 14 Aug 2026 | Resignation of Director/KMP/SMP | −1.2% | −4.6% |
| 14 Aug 2026 | Resignation of Bhaveshkumar Popatlal Upadhyay as Non- Executive… | −1.2% | −4.6% |
What to watch
- The appointment of a successor and any change in strategy or guidance.
- 5 November 2026: Board meeting — Fund Raising/Other business matters.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.